Bill Snyder

iStock Photo
July 24, 2017

How Epo action is ‘enhanced’

The hormone erythropoietin (Epo) controls red blood cell production and synthetic forms of Epo treat multiple disorders. New Vanderbilt research details how Epo works.

July 20, 2017

Study identifies protein’s role in chemotherapy resistance

Researchers at Vanderbilt University Medical Center (VUMC) have discovered a protein that may lead to a new way to prevent resistance and improve outcomes for patients whose cancers have mutations in the tumor suppressor gene BRCA2.

July 20, 2017

Immune responses linked to cell’s recycling system

Autophagy is the cellular equivalent of trash pickup and recycling — it is a process by which proteins, protein aggregates and damaged cellular organelles are degraded in order to reuse nutrients and promote cellular metabolism.

July 20, 2017

eSmart portal set to bolster clinical research enterprise

About 250 research staff members attended an EpicLeap for Research Town Hall on Monday to learn what they must do to prepare for the Nov. 2 launch of eStar, Vanderbilt University Medical Center’s version of the Epic clinical, administrative and billing software system.

July 13, 2017

Lindsell named to key VICTR, IMPH and Biostatistics leadership roles

Christopher Lindsell, Ph.D., nationally known for building clinical, translational and emergency medicine research programs at the University of Cincinnati, has been named director of the Research Methods Program in the Vanderbilt Institute of Clinical and Translational Research (VICTR).

storming night with many bolts of lightning
June 22, 2017

VU scientists report a way to calm the sepsis “storm”

Researchers at Vanderbilt University Medical Center (VUMC) have found a way to calm the “genomic storm” that triggers the often-lethal consequences of sepsis.